期刊
ARTHRITIS CARE & RESEARCH
卷 68, 期 1, 页码 1-25出版社
WILEY
DOI: 10.1002/acr.22783
关键词
-
类别
资金
- American College of Rheumatology
- Savient
- Allergan
- Regeneron
- Merz
- Iroko
- Bioiberica
- Takeda
- Dinora
- Horizon
- Abbott
- Amgen
- Bayer
- Bristol-Myers Squibb
- Lilly
- Merck
- Pfizer
- Roche/Genentech
- Ardea/AstraZeneca
- Crescendo
- AbbVie
- UCB
- Janssen
- Consortium of Rheumatology Researchers of North America (CORRONA) registry
- Actelion
- Cytori
- Gilead
- GlaxoSmithKline
- Novartis
- Roche
- Medac
- Antaes
- Medical Director of the North Mississippi Arthritis and Research Center
- Zimmer
- Mesoblast
- Genentech
- Ardea
- Sanofi
- Centocor
- Celgene
- Biogen
- Sanofi-Aventis
- Samumed
- Fidia
- Flexion
- McNeil Consumer Healthcare
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to the recommendations within this guideline to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed and endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice. ACR recommendations are not intended to dictate payment or insurance decisions. These recommendations cannot adequately convey all uncertainties and nuances of patient care. The ACR is an independent, professional, medical and scientific society that does not guarantee, warrant, or endorse any commercial product or service.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据